{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:41:51Z","timestamp":1792320111708,"version":"4.4.0"},"reference-count":24,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in infants, with the highest burden in the first 6 months of life. Maternal immunization with the bivalent (RSV-A and RSV-B) prefusion F (RSVPreF) protein subunit vaccine (ABRYSVO) is a recently recommended strategy for preventing RSV-related outcomes in infants. First licensed for use in pregnancy in 2023, the RSVPreF vaccine demonstrated efficacy in a single pivotal randomized trial (Maternal Immunization Study for Safety and Efficacy; MATISSE); postlicensure real-world evidence on vaccine effectiveness across settings, seasons, and subgroups and on antibody durability and transplacental transfer remains limited and has not been synthesized in a continuously updated framework, motivating this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This living systematic review and meta-analysis will synthesize emerging postlicensure data on the efficacy, effectiveness, and immunogenicity of the RSVPreF vaccine in real-world settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We will conduct, in real time, a living systematic review and meta-analysis following Cochrane methods and PRISMA-P (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols) guidance, including randomized clinical trials and postlicensure real-world studies (eg, cohort, case-control, test-negative, and quasi-experimental studies). Primary objectives are evaluation of vaccine efficacy and effectiveness in preventing RSV-specific and all-cause respiratory disease and immunogenicity in infants and pregnant individuals. Vaccine effectiveness outcomes include RSV laboratory-confirmed infection, RSV acute respiratory illness, RSV lower respiratory tract disease, RSV hospitalization, RSV complications, all-cause lower respiratory tract disease and hospitalization, and antibiotic use in infants with RSV infection. Immunogenicity outcomes include maternal neutralizing antibody titers, maternal-infant transfer ratios, infant titers over time, and RSV viral load. We will search MEDLINE, Embase, the Cochrane Library, LILACS, Science Citation Index Expanded, Chinese biomedical and citation databases, clinical trial registries from January 2023 onward with no language restrictions, updating at least monthly. Two investigators will independently select studies, extract data, and assess risk of bias. Adjusted estimates will be standardized to vaccine efficacy and effectiveness. Certainty will be graded using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This living systematic review was funded in June 2025. Searches began in January 2023 and will continue with surveillance updates at least monthly until April 2028. As of January 2026, 837 records were screened, 105 (12.5%) were assessed in full text, and 12 (1.4%) met the inclusion criteria, of which 10 (1.2%) contributed extractable data. Data collection and analysis are ongoing and displayed on an interactive dashboard. Findings will be disseminated through peer-reviewed publications, conferences, and a real-time dashboard, with the first effectiveness estimates available in July 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This living systematic review and meta-analysis will provide a continuously updated synthesis of real-world evidence on maternal RSVPreF vaccination to inform clinical and policy decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/94382","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:24:52Z","timestamp":1792319092000},"page":"e94382-e94382","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy, Effectiveness, and Immunogenicity of the Respiratory Syncytial Virus Prefusion F Vaccine Administered During Pregnancy: Protocol for a Living Systematic Review and Meta-Analysis"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3328-2705","authenticated-orcid":false,"given":"Agustina","family":"Mazzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-0073","authenticated-orcid":false,"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-5643","authenticated-orcid":false,"given":"Mabel","family":"Berrueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-6122","authenticated-orcid":false,"given":"Agustin","family":"Ciapponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-5432","authenticated-orcid":false,"given":"Karen","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-449X","authenticated-orcid":false,"given":"Martin","family":"Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6689-514X","authenticated-orcid":false,"given":"Carolina","family":"Nigri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2937-0835","authenticated-orcid":false,"given":"Noelia","family":"Castellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-8040","authenticated-orcid":false,"given":"Jamile","family":"Ballivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-2469","authenticated-orcid":false,"given":"Juan Manuel","family":"Sambade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3427-0630","authenticated-orcid":false,"given":"Katharina","family":"Stegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0288-1115","authenticated-orcid":false,"given":"Divya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-6456","authenticated-orcid":false,"given":"Jessica E","family":"Atwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1535-1076","authenticated-orcid":false,"given":"Jennifer","family":"Deese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-0504","authenticated-orcid":false,"given":"Sarah N","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9531-6086","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-5059","authenticated-orcid":false,"given":"Xu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-6627","authenticated-orcid":false,"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-7689","authenticated-orcid":false,"given":"Flor M","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4294-8559","authenticated-orcid":false,"given":"Pierre","family":"Buekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"10098","key":"R1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","journal-title":"Lancet"},{"issue":"10340","key":"R2","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","journal-title":"Lancet"},{"key":"R3","unstructured":"ABRYSVO. U.S. Food & Drug Administration. URL: https:\/\/www.fda.gov\/vaccines-blood-biologics\/abrysvo [Accessed 26-09-2026]"},{"key":"R4","unstructured":"Abrysvo. European Medicines Agency. 2023. URL: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abrysvo [Accessed 16-09-2025]"},{"key":"R5","unstructured":"Abrysvo. World Health Organization. URL: https:\/\/extranet.who.int\/prequal\/vaccines\/p\/abrysvo [Accessed 16-09-2025]"},{"issue":"16","key":"R6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","journal-title":"N Engl J Med"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/AOG.0000000000005816","article-title":"Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial","volume":"145","author":"Sim\u00f5es","journal-title":"Obstet Gynecol"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107118","article-title":"Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: a systematic review and meta-analysis","volume":"146","author":"Zeng","journal-title":"Int J Infect Dis"},{"issue":"9","key":"R9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD016131","article-title":"Efficacy and safety of respiratory syncytial virus vaccines","volume":"9","author":"Saif-Ur-Rahman","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"R10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015134.pub2","article-title":"Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes","volume":"5","author":"Phijffer","journal-title":"Cochrane Database Syst Rev"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1566-9_7","article-title":"Living systematic reviews","volume":"2345","author":"Simmonds","journal-title":"Methods Mol Biol"},{"issue":"10","key":"R12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","journal-title":"Cochrane Database Syst Rev"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","journal-title":"BMJ"},{"key":"R14","unstructured":"PROSPERO. Centre for Reviews and Dissemination, University of York. URL: https:\/\/www.crd.york.ac.uk\/PROSPERO\/authorapproval\/AE1061F2-C9AE-45BE-8CB5-2DF205227A75 [Accessed 16-09-2025]"},{"key":"R15","unstructured":"Nested Knowledge. URL: https:\/\/nested-knowledge.com\/ [Accessed 26-09-2026]"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"key":"R17","unstructured":"Current version of RoB 2. Risk of Bias. URL: https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2 [Accessed 16-09-2025]"},{"key":"R18","unstructured":"ROBINS-I tool resources and reporting guidance. The Cochrane Collaboration. URL: https:\/\/www.cochrane.org\/learn\/courses-and-resources\/cochrane-methodology\/risk-bias\/robins-i-tool-resources-and-reporting-guidance [Accessed 16-09-2025]"},{"key":"R19","unstructured":"JBI Global. URL: https:\/\/jbi.global [Accessed 16-09-2025]"},{"issue":"7109","key":"R20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","journal-title":"BMJ"},{"key":"R21","unstructured":"Power BI. URL: https:\/\/app.powerbi.com\/singleSignOn?ru=https%3A%2F%2Fapp.powerbi.com%2Fhome%3FnoSignUpCheck%3D1 [Accessed 16-09-2025]"},{"key":"R22","unstructured":"Gebre K . Modern Statistical Computing and Data Analysis with RStudio and SAS. LAP LAMBERT Academic Publishing; 2025. ISBN: 9786206844327"},{"key":"R23","unstructured":"GRADE handbook. The GRADE Working Group. URL: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html [Accessed 09-04-2025]"},{"key":"R24","unstructured":"Safe in Pregnancy. URL: https:\/\/safeinpregnancy.org\/ [Accessed 29-09-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:24:59Z","timestamp":1792319099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e94382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2196\/94382","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"article-number":"v15i10098e94382"}}